ABVC BioPharma Inc (ABVC)
0.5306
0.00 (0.00%)
USD |
NASDAQ |
Nov 14, 12:19
ABVC BioPharma Revenue (Quarterly): 0.1171M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.1171M |
| March 31, 2024 | 0.0012M |
| December 31, 2023 | 0.0022M |
| September 30, 2023 | 0.0159M |
| June 30, 2023 | 0.0061M |
| March 31, 2023 | 0.1283M |
| December 31, 2022 | 0.589M |
| September 30, 2022 | 0.0423M |
| June 30, 2022 | 0.3129M |
| March 31, 2022 | 0.0257M |
| December 31, 2021 | -0.0378M |
| September 30, 2021 | 0.099M |
| June 30, 2021 | 0.0314M |
| March 31, 2021 | 0.2631M |
| December 31, 2020 | 0.0622M |
| September 30, 2020 | 0.1156M |
| June 30, 2020 | 0.2265M |
| March 31, 2020 | 0.0788M |
| December 31, 2019 | 0.10M |
| September 30, 2019 | 0.1977M |
| June 30, 2019 | 0.1918M |
| March 31, 2019 | 0.2122M |
| December 31, 2018 | -0.004M |
| September 30, 2018 | 0.0007M |
| June 30, 2018 | 0.0032M |
| Date | Value |
|---|---|
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | 0.0011M |
| June 30, 2015 | |
| March 31, 2015 | 0.0023M |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | 0.0008M |
| December 31, 2012 | 0.007M |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | 0.0037M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
-0.0378M
Minimum
Dec 2021
0.589M
Maximum
Dec 2022
0.1147M
Average
0.0788M
Median
Mar 2020
Revenue (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 2.40M |
| Palatin Technologies Inc | 0.35M |
| iBio Inc | 0.175M |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.013M |
| Total Expenses (Quarterly) | 1.094M |
| EPS Diluted (Quarterly) | -0.09 |
| Enterprise Value | 7.784M |
| Gross Profit Margin (Quarterly) | 99.84% |
| Profit Margin (Quarterly) | -864.5% |
| Earnings Yield | -321.0% |
| Normalized Earnings Yield | -317.51 |